Open Journal of Rheumatology and Autoimmune Diseases

Vol.8 No.4(2018), Paper ID 88171, 9 pages

DOI:10.4236/ojra.2018.84012

 

Review Venous Thromboembolism Risk with Anti-Osteoporosis Drugs

 

Kawtar Nassar, Wafae Rachidi, Saadia Janani, Ouafa Mkinsi

 

Department of Rheumatology, Ibn Rochd University Hospital Center, Medicine and Pharmacy University of Casablanca, Casablanca, Morocco
Department of Rheumatology, Ibn Rochd University Hospital Center, Medicine and Pharmacy University of Casablanca, Casablanca, Morocco
Department of Rheumatology, Ibn Rochd University Hospital Center, Medicine and Pharmacy University of Casablanca, Casablanca, Morocco
Department of Rheumatology, Ibn Rochd University Hospital Center, Medicine and Pharmacy University of Casablanca, Casablanca, Morocco

 

Copyright © 2018 Kawtar Nassar, Wafae Rachidi, Saadia Janani, Ouafa Mkinsi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Nassar, K. , Rachidi, W. , Janani, S. and Mkinsi, O. (2018) Review Venous Thromboembolism Risk with Anti-Osteoporosis Drugs. Open Journal of Rheumatology and Autoimmune Diseases, 8, 111-119. doi: 10.4236/ojra.2018.84012.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.